Skip to content
If you're looking for a multi-bagger, there's a few things to keep an eye out for. In a perfect world, we'd like to......
(Bloomberg) -- A coronavirus vaccine the University of Oxford is developing with AstraZeneca Plc showed promising results in early human testing, a sign of progress in the high-stakes pursuit of a shot to defeat the pathogen.The vaccine increased levels of both protective neutralizing antibodies and immune T-cells that target the virus, according to the study organizers. The results were published Monday in The Lancet medical journal.AstraZeneca shares rose as much as 10% in London.“We are seeing very good immune responses, not just on neutralizing antibodies but of T-cells as well,” said Adrian Hill, head of Oxford’s Jenner Institute, in an interview. “We’re stimulating both arms of the immune system.”The results will be closely scrutinized as governments around the world seek to end a pandemic that’s killed more than 600,000 people and triggered economic turmoil since erupting earlier this year. Moderna Inc., another front-runner, released results last week from an early-stage test...
Yahoo Finance’s Alexis Christoforous, Brian Sozzi, and Emily McCormick discuss Chevron’s deal with Noble Energy, Halliburton earnings, and preview the earnings week ahead....
The U.S. is testing more and more Americans for COVID-19, but Dr. Dara Kass, a Yahoo medical contributor and associate professor of emergency medicine at Columbia University, says additional testing is not the reason why cases are spiking. She speaks with Yahoo Finance’s Alexis Christoforous, Brian Sozzi and Editor-in-Chief Andy Serwer....
Samsara announced the winners of its annual 2020 Top Fleet Awards honoring the exceptional fleets that power the economy, from waste services to for-hire operations. ...
When comparing propane to electric, fleets should examine factors around emissions, economics, and fueling. ...
The markets have been showing mixed messages lately. A look at the chart shows that the NASDAQ’s rate of climb has been slowing recently, although it remains at record high levels. At the same time, the S&P 500 is holding just over 3,200, putting the index back within 5% of its all-time peak – but the Dow Jones appears to have hit a plateau. All of this raises some questions about the future of the market’s bull rally.Chief among those questions are worries about the resurgence of COVID-19 and the possibility of further lockdown policies. The state of California – which by itself is the world’s fifth largest economy, valued at over $2.6 trillion – has recently reimposed severe social distancing rules along with restrictions on businesses. Even Texas has imposed a mask mandate.Worried investors are looking for safety, which will naturally renew interest in dividend stocks. But not just any...
